Home » Topics » BioWorld Science

BioWorld Science
RSS

Arcutis plans phase III program with ARQ-151 for plaque psoriasis

Oct. 28, 2019

Antimalarial agents detailed in UCB patent

Oct. 28, 2019

TaiMed Biologics discontinues development of TMB-607

Oct. 28, 2019

Y-mAbs announces presentation of data on naxitamab for neuroblastoma and osteosarcoma

Oct. 28, 2019

FUJIFILM synthesizes beta-lactams

Oct. 28, 2019

Merck & Co. presents new hSTING agonists

Oct. 28, 2019

Silverback Therapeutics discloses TGFR-1 inhibitors

Oct. 28, 2019

Betta Pharmaceuticals divulges new PD-1/PD-L1 interaction inhibitors

Oct. 28, 2019

Metastases, tumors, similar in broad view, different in detail

Oct. 28, 2019

New antibiotic class fights colistin-resistant bugs

Oct. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...